These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 2405151

  • 1. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
    Le Monnier de Gouville AC, Mondot S, Lippton H, Hyman A, Cavero I.
    J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
    [Abstract] [Full Text] [Related]

  • 2. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
    Cavero I, Mondot S, Mestre M.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353
    [Abstract] [Full Text] [Related]

  • 3. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
    Cavero I, Pratz J, Mondot S.
    Z Kardiol; 1991 Mar; 80 Suppl 7():35-41. PubMed ID: 1838848
    [Abstract] [Full Text] [Related]

  • 4. Vasodilator activity of endothelin-1 and endothelin-3: rapid development of cross-tachyphylaxis and dependence on the rate of endothelin administration.
    Le Monnier de Gouville AC, Lippton H, Cohen G, Cavero I, Hyman A.
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1024-8. PubMed ID: 2118569
    [Abstract] [Full Text] [Related]

  • 5. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
    Pratz J, Mondot S, Montier F, Cavero I.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):216-22. PubMed ID: 1906538
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I, Lefevre-Borg F, Lhoste F, Sabatier C, Richer C, Giudicelli JF.
    J Pharmacol Exp Ther; 1984 Mar 01; 228(3):779-91. PubMed ID: 6707926
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K, Barras M, Zazzi-Sudriez E, Martin DJ, Armstrong JM, Hicks PE.
    Br J Pharmacol; 1992 Sep 01; 107(1):58-65. PubMed ID: 1422579
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I, Lorrain J, Di Paola ED, Lhoste F, Payen B, Dennis T, Scatton B.
    J Pharmacol Exp Ther; 1985 Dec 01; 235(3):798-809. PubMed ID: 2934543
    [Abstract] [Full Text] [Related]

  • 9. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.
    Le Monnier de Gouville AC, Cavero I.
    Br J Pharmacol; 1991 Sep 01; 104(1):77-84. PubMed ID: 1786522
    [Abstract] [Full Text] [Related]

  • 10. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM, Kemp PA, Brunner-Ferber F, Bennett T.
    Br J Pharmacol; 1997 Dec 01; 122(8):1687-93. PubMed ID: 9422815
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the hemodynamic effects of endothelin-1 and sarafotoxin S6b in conscious rats.
    Han SP, Trapani AJ, Fok KF, Westfall TC, Knuepfer MM.
    J Pharmacol Exp Ther; 1991 Jan 01; 256(1):183-8. PubMed ID: 1988658
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U, Cook NS.
    J Pharmacol Exp Ther; 1989 Jul 01; 250(1):261-71. PubMed ID: 2501478
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
    Clapham JC, Hamilton TC, Longman SD, Buckingham RE, Campbell CA, Ilsley GL, Gout B.
    Arzneimittelforschung; 1991 Apr 01; 41(4):385-91. PubMed ID: 1907150
    [Abstract] [Full Text] [Related]

  • 14. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I, Lefèvre-Borg F, Gomeni R.
    J Pharmacol Exp Ther; 1981 Aug 01; 218(2):515-24. PubMed ID: 7252851
    [Abstract] [Full Text] [Related]

  • 15. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC, Lawson K, Thiry C, Cavero I.
    J Pharmacol Exp Ther; 1991 Mar 01; 256(3):1049-56. PubMed ID: 1672375
    [Abstract] [Full Text] [Related]

  • 16. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB, Giardino EC, Salata JJ, Moore JB, Falotico R.
    J Pharmacol Exp Ther; 1993 Nov 01; 267(2):648-56. PubMed ID: 8246137
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat.
    Sirén AL, Feuerstein G.
    J Pharmacol Exp Ther; 1988 Oct 01; 247(1):69-78. PubMed ID: 2459371
    [Abstract] [Full Text] [Related]

  • 18. Differential pharmacological profile of endothelin-1 and its precursor, big endothelin.
    Le Monnier de Gouville AC, Cavero I.
    J Cardiovasc Pharmacol; 1991 Oct 01; 17 Suppl 7():S362-5. PubMed ID: 1725381
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB, Bennett T, Randall MD, Gardiner SM.
    Br J Pharmacol; 1998 Apr 01; 123(7):1367-74. PubMed ID: 9579732
    [Abstract] [Full Text] [Related]

  • 20. Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.
    Buckingham RE.
    Br J Pharmacol; 1988 Mar 01; 93(3):541-52. PubMed ID: 3370388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.